HCAT
Health Catalyst, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
-7/100
Last price
1.77
▲ 0.01 (0.57%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.77
Prev close
1.76
Day high
1.81
Day low
1.75
Volume
225.22K
Market cap
$133.20M
P/E (TTM)
—
52W range
0.96 – 3.62
Day trading desk
Gap from prior close
+0.57%
Prior close 1.76
VWAP
1.78
-0.53% from price
Relative volume
0.33×
Quiet session
Session range
3.43%
1.75 – 1.81
Position in range
33%
Mid range
ATR (14D)
0.08
4.48% of price
Prior day high
1.79
PDH
Prior day low
1.73
PDL
Bid / ask spread
—
Quote not published
Session volume
214.67K
Avg 642.02K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.14%
-0.8%
1M
+4.73%
+3.6%
3M
-19.55%
-24.1%
6M
+60.91%
+42.7%
YTD
-25.94%
-40.2%
1Y
-40.20%
-56.6%
3Y
-82.51%
-164.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HCAT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
7.06M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 14, 26 | KOHL SIMEON M Chief Executive Officer |
BUY | 59.00K | $105.44K | Direct |
| Sep 14, 26 | KOHL SIMEON M Chief Executive Officer |
STOCK | 2.75M | $0 | Direct |
| Sep 1, 26 | LARSON-GREEN JULIE Director |
STOCK | 9.77K | $0 | Direct |
| Jul 16, 26 | LARSON-GREEN JULIE Director |
STOCK | 80.69K | $0 | Direct |
| Jul 16, 26 | HOGGARD GREEN JILL Director |
STOCK | 80.69K | $0 | Direct |
| Jul 16, 26 | NELSON STEVEN H Director |
STOCK | 80.69K | $0 | Direct |
| Jul 16, 26 | SPENCER JUSTIN R. Director |
STOCK | 80.69K | $0 | Direct |
| Jun 1, 26 | LARSON-GREEN JULIE Director |
STOCK | 12.71K | $0 | Direct |
| May 1, 26 | NELSON STEVEN H Director |
STOCK | 154.81K | $0 | Direct |
| Apr 29, 26 | ALBERT BENJAMIN Chief Executive Officer |
STOCK | 1.12K | $0 | Direct |
| Feb 27, 26 | LARSON-GREEN JULIE Director |
STOCK | 8.36K | $0 | Direct |
| Feb 25, 26 | ALGER JASON Chief Financial Officer |
STOCK | 529.72K | $0 | Direct |
| Feb 25, 26 | LANDRY BENJAMIN General Counsel |
STOCK | 305.47K | $0 | Direct |
| Feb 25, 26 | ALBERT BENJAMIN Chief Executive Officer |
STOCK | 968.83K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALBERT BENJAMIN |
Chief Executive Officer | 1.46M | Stock Award(Grant) |
ALGER JASON |
Chief Financial Officer | 768.61K | Stock Award(Grant) |
BURTON DANIEL D |
Chief Executive Officer | 1.50M | Stock Award(Grant) |
FREEMAN KEVIN LEE |
Officer | 395.21K | Stock Award(Grant) |
KOHL SIMEON M |
Chief Executive Officer | 2.86M | Purchase |
LANDRY BENJAMIN |
General Counsel | 399.16K | Stock Award(Grant) |
LARSON-GREEN JULIE |
Director | 185.10K | Stock Award(Grant) |
LESUEUR DANIEL |
Chief Operating Officer | 205.83K | Sale |
LLEWELYN LINDA |
Officer | 343.49K | Stock Award(Grant) |
NELSON STEVEN H |
Director | 235.50K | Stock Award(Grant) |
Fundamentals
Market cap$133.20M
Enterprise value$199.74M
Revenue (TTM)$292.24M
Gross profit$149.52M
EBITDA$11.77M
Net income$-264.82M
EPS (TTM)$-3.69
Free cash flow$-48.65M
Total cash$103.44M
Total debt$169.98M
Book value / share$1.35
Shares outstanding75.26M
Float59.27M
Short % of float3.31%
Dividend yield0.00%
Beta (5Y)1.54
Valuation & profitability ratios
Trailing P/E—
Forward P/E236.00
PEG ratio—
Price / sales—
Price / book1.31
EV / revenue0.68
EV / EBITDA16.97
Gross margin51.16%
Operating margin-5.35%
Profit margin-90.61%
Return on equity-118.12%
Return on assets-3.02%
Debt / equity168.58
Current ratio2.70
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $311.14M | $306.58M | $295.94M | $276.24M | +1.5% |
| Operating revenue | $311.14M | $306.58M | $295.94M | $276.24M | +1.5% |
| Cost of revenue | $159.46M | $165.81M | $164.10M | $143.05M | -3.8% |
| Gross profit | $151.68M | $140.78M | $131.83M | $133.19M | +7.7% |
| Research & development | $49.77M | $57.95M | $72.63M | $75.68M | -14.1% |
| Selling, general & admin | $94.15M | $99.01M | $116.98M | $149.22M | -4.9% |
| Total operating expense | $194.42M | $198.39M | $231.83M | $273.19M | -2.0% |
| Operating income | -$42.74M | -$57.61M | -$100.00M | -$140.00M | +25.8% |
| Net interest income | -$16.72M | $896.00K | $9.11M | -$1.68M | -1,966.0% |
| Pre-tax income | -$177.26M | -$69.17M | -$117.79M | -$141.68M | -156.3% |
| Tax provision | $716.00K | $333.00K | $356.00K | -$4.28M | +115.0% |
| Net income | -$177.97M | -$69.50M | -$118.15M | -$137.40M | -156.1% |
| Net income to common | -$177.97M | -$69.50M | -$118.15M | -$137.40M | -156.1% |
| Basic EPS | -2.55 | -1.15 | -2.09 | -2.56 | -121.7% |
| Diluted EPS | -2.55 | -1.15 | -2.09 | -2.63 | -121.7% |
| EBIT | -$153.00M | -$52.08M | -$100.00M | -$140.00M | -193.8% |
| EBITDA | -$102.50M | -$10.65M | -$57.78M | -$91.71M | -862.3% |
| Basic shares | 69.90M | 60.19M | 56.42M | 53.72M | +16.1% |
| Diluted shares | 69.90M | 60.19M | 56.42M | 54.08M | +16.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $50.81M | $249.65M | $106.28M | $116.31M | -79.6% |
| Cash & short-term investments | $95.73M | $392.00M | $317.73M | $363.49M | -75.6% |
| Accounts receivable | $59.13M | $57.18M | $60.29M | $47.97M | +3.4% |
| Total current assets | $169.31M | $465.65M | $393.40M | $427.80M | -63.6% |
| Property, plant & equipment | $40.48M | $41.45M | $39.64M | $42.59M | -2.3% |
| Goodwill & intangibles | $286.75M | $345.81M | $264.04M | $278.17M | -17.1% |
| Total assets | $502.64M | $858.93M | $701.81M | $752.29M | -41.5% |
| Total current liabilities | $89.57M | $325.85M | $89.03M | $82.51M | -72.5% |
| Current debt | $1.63M | $231.18M | — | — | -99.3% |
| Long-term debt | $151.62M | $151.18M | $228.03M | $226.52M | +0.3% |
| Total debt | $171.24M | $402.26M | $249.07M | $247.97M | -57.4% |
| Total liabilities | $256.86M | $493.72M | $334.89M | $327.28M | -48.0% |
| Retained earnings | -$1.36B | -$1.19B | -$1.12B | -$999.02M | -15.0% |
| Shareholder equity | $245.78M | $365.21M | $366.92M | $425.01M | -32.7% |
| Working capital | $79.73M | $139.80M | $304.36M | $345.29M | -43.0% |
| Net tangible assets | -$40.97M | $19.40M | $102.88M | $146.84M | -311.2% |
| Shares issued | 72.03M | 64.04M | 58.30M | 55.26M | +12.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$177.97M | -$69.50M | -$118.15M | -$137.40M | -156.1% |
| Depreciation & amortisation | $50.50M | $41.43M | $42.22M | $48.30M | +21.9% |
| Stock-based compensation | $27.01M | $40.13M | $55.76M | $72.10M | -32.7% |
| Change in working capital | -$15.11M | -$660.00K | -$13.67M | -$13.91M | -2,189.7% |
| Operating cash flow | $731.00K | $14.56M | -$33.08M | -$35.27M | -95.0% |
| Capital expenditure | -$21.55M | -$16.40M | -$14.31M | -$17.41M | -31.4% |
| Investing cash flow | $36.19M | -$22.90M | $20.29M | -$39.02M | +258.0% |
| Share buybacks | -$5.00M | $0 | -$1.81M | -$8.39M | — |
| Financing cash flow | -$235.78M | $151.75M | $2.73M | -$2.61M | -255.4% |
| Free cash flow | -$20.82M | -$1.84M | -$47.39M | -$52.68M | -1,032.2% |
| End cash position | $50.81M | $249.65M | $106.28M | $116.31M | -79.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $70.49M | $70.76M | $74.68M | $76.32M | $80.72M | -0.4% |
| Operating revenue | $70.49M | $70.76M | $74.68M | $76.32M | $80.72M | -0.4% |
| Cost of revenue | $35.63M | $35.29M | $35.30M | $38.51M | $42.48M | +0.9% |
| Gross profit | $34.86M | $35.46M | $39.38M | $37.82M | $38.24M | -1.7% |
| Research & development | $11.03M | $9.78M | $9.91M | $12.28M | $12.39M | +12.8% |
| Selling, general & admin | $22.29M | $20.73M | $13.33M | $30.43M | $21.49M | +7.5% |
| Total operating expense | $44.29M | $42.63M | $36.12M | $55.33M | $46.57M | +3.9% |
| Operating income | -$9.43M | -$7.16M | $3.26M | -$17.51M | -$8.32M | -31.7% |
| Net interest income | -$3.72M | -$3.94M | -$4.61M | -$4.50M | -$4.13M | +5.7% |
| Pre-tax income | -$40.22M | -$110.61M | -$90.65M | -$22.19M | -$40.90M | +63.6% |
| Tax provision | $315.00K | $414.00K | $379.00K | $41.00K | $81.00K | -23.9% |
| Net income | -$40.54M | -$111.03M | -$91.03M | -$22.23M | -$40.98M | +63.5% |
| Net income to common | -$40.54M | -$111.03M | -$91.03M | -$22.23M | -$40.98M | +63.5% |
| Basic EPS | -0.55 | -1.53 | -1.28 | -0.32 | -0.59 | +64.1% |
| Diluted EPS | -0.55 | -1.53 | -1.28 | -0.32 | -0.59 | +64.1% |
| EBIT | -$35.58M | -$105.87M | -$85.13M | -$16.55M | -$35.11M | +66.4% |
| EBITDA | -$24.60M | -$93.75M | -$72.25M | -$3.94M | -$22.43M | +73.8% |
| Basic shares | 73.96M | 72.59M | 71.00M | 70.38M | 69.63M | +1.9% |
| Diluted shares | 73.96M | 72.59M | 71.00M | 70.38M | 69.63M | +1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $60.59M | $59.86M | $50.81M | $40.30M | $50.71M | +1.2% |
| Cash & short-term investments | $103.44M | $108.82M | $95.73M | $91.54M | $97.34M | -4.9% |
| Accounts receivable | $41.90M | $59.15M | $59.13M | $60.11M | $68.38M | -29.2% |
| Total current assets | $248.39M | $182.31M | $169.31M | $165.35M | $180.58M | +36.2% |
| Property, plant & equipment | $39.41M | $41.19M | $40.48M | $39.87M | $45.74M | -4.3% |
| Goodwill & intangibles | $67.22M | $182.58M | $286.75M | $375.14M | $384.44M | -63.2% |
| Total assets | $358.60M | $412.20M | $502.64M | $587.13M | $616.18M | -13.0% |
| Total current liabilities | $91.92M | $107.61M | $89.57M | $87.89M | $98.82M | -14.6% |
| Current debt | $1.63M | $1.63M | $1.63M | $1.63M | $1.63M | 0.0% |
| Long-term debt | $151.85M | $151.74M | $151.62M | $151.51M | $151.40M | +0.1% |
| Total debt | $169.98M | $170.58M | $171.24M | $172.12M | $172.79M | -0.4% |
| Total liabilities | $257.78M | $274.06M | $256.86M | $255.21M | $268.63M | -5.9% |
| Retained earnings | -$1.52B | -$1.48B | -$1.36B | -$1.27B | -$1.25B | -2.7% |
| Shareholder equity | $100.83M | $138.15M | $245.78M | $331.92M | $347.55M | -27.0% |
| Working capital | $156.47M | $74.70M | $79.73M | $77.46M | $81.75M | +109.5% |
| Net tangible assets | $33.60M | -$44.44M | -$40.97M | -$43.22M | -$36.89M | +175.6% |
| Shares issued | 74.60M | 73.75M | 72.03M | 70.62M | 70.27M | +1.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$40.54M | -$111.03M | -$91.03M | -$22.23M | -$40.98M | — | +63.5% |
| Depreciation & amortisation | $10.98M | $12.12M | $12.88M | $12.61M | $12.68M | — | -9.4% |
| Stock-based compensation | $2.71M | $3.77M | $4.11M | $7.04M | $8.32M | — | -28.1% |
| Change in working capital | -$1.01M | $16.29M | $994.00K | -$4.83M | -$13.82M | — | -106.2% |
| Operating cash flow | $275.00K | $18.51M | $9.91M | -$464.00K | -$9.00M | — | -98.5% |
| Capital expenditure | -$5.46M | -$5.50M | -$5.60M | -$5.13M | -$5.49M | — | +0.7% |
| Investing cash flow | $902.00K | -$9.41M | $1.01M | -$9.35M | -$52.23M | — | +109.6% |
| Share buybacks | $0 | $0 | $0 | $0 | $0 | — | — |
| Financing cash flow | -$450.00K | -$4.00K | -$434.00K | -$537.00K | -$230.10M | — | -11,150.0% |
| Free cash flow | -$5.18M | $13.02M | $4.32M | -$5.60M | -$14.49M | — | -139.8% |
| End cash position | — | — | $50.81M | $40.30M | $50.71M | $341.97M | — |
Options analytics
Put / call volume
0.04
Call-heavy session
Put / call open interest
0.00
Positioning, not flow
Max pain
2.00
+13.0% from spot
ATM implied vol
25.0%
Nearest strike to spot
Skew (10% OTM)
-25.0%
Calls bid over puts
Call volume
56
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
2.50
1.10K contracts
Heaviest put OI
2.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.03 | 0.04 | +30.7% |
| Mar 2026 | 0.01 | 0.02 | +85.9% |
| Dec 2025 | 0.10 | 0.08 | -16.1% |
| Sep 2025 | 0.07 | 0.06 | -8.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.05 | 4 | $55.38M | -27.4% |
| Next quarter | -0.04 | 4 | $51.18M | -31.5% |
| Current year | -0.04 | 4 | $247.81M | -20.3% |
| Next year | 0.01 | 4 | $205.54M | -17.1% |
Analyst targets & ownership
Mean target$1.77
High target$2.00
Low target$1.50
Implied upside-0.19%
Analyst count3
ConsensusHOLD
Strong buy / Buy0 / 1
Hold4
Sell / Strong sell0 / 0
Held by insiders9.38%
Held by institutions71.51%
Institutions holding161
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.74
+1.55% from price
SMA 20
1.76
+0.71% from price
SMA 50
1.80
-1.39% from price
SMA 100
1.80
-1.51% from price
SMA 200
1.78
-0.28% from price
EMA 12
1.75
+1.05% from price
EMA 26
1.76
+0.81% from price
EMA 50
1.78
-0.43% from price
RSI (14)
51.3
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.08
4.48% of price
Realised vol 30D
46.5%
Annualised
Bollinger upper
1.85
20, 2σ
Bollinger lower
1.67
20, 2σ
50 / 200 cross
Golden
1.80 vs 1.78
Trend bias
Below 200
-0.28%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.35
More volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
46.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-71.2%
Peak to trough
Max drawdown 5Y
-98.2%
Peak to trough
ATR 14
0.08
4.48% of price
Beta (reported)
1.54
5Y monthly, from filing
Short interest
Shares short
2.03M
Prior 2.29M
Change vs prior
-11.4%
Shorts covering
% of float
3.31%
Normal
% of shares out
2.70%
Against total outstanding
Days to cover
4.0
Liquid
Float
59.27M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 26 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| Aug 13, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 11, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jun 26, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| May 12, 26 | Stephens & Co. | MAINTAINED | Equal-Weight | Equal-Weight |
| Mar 18, 26 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Mar 13, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Mar 13, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Mar 13, 26 | Stephens & Co. | MAINTAINED | Equal-Weight | Equal-Weight |
| Mar 13, 26 | Stifel | MAINTAINED | Hold | Hold |
| Mar 13, 26 | Cantor Fitzgerald | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-14
Corporate Changes & Voting Matters
8-K · 2026-09-08
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-20
Corporate Changes & Voting Matters
8-K · 2026-06-04
Proxy Statements
DEF 14A · 2026-06-03
Proxy Statements
PRE 14A · 2026-05-19
Corporate Changes & Voting Matters
8-K · 2026-05-11
Headlines
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 7d ago
3 Software Stocks We’re Skeptical Of
StockStory · 9d ago
3 Unprofitable Stocks That Fall Short
StockStory · 12d ago
Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks
Simply Wall St. · 18d ago
3 Small-Cap Stocks We Steer Clear Of
StockStory · 18d ago
Population Health Management Market by Component, Functionality, End User, Organization Size - Global Forecast to 2031
GlobeNewswire · 19d ago
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 22d ago
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
PR Newswire · 22d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.